Yahoo Web Search

  1. Ads

    related to: alpha-1 antitrypsin deficiency (aatd)

Search results

    • Sanofi to buy Inhibrx in deal worth up to $2.2B

      Sanofi to buy Inhibrx in deal worth up to $2.2B

      BioPharma Dive via Yahoo Finance· 4 months ago

      The acquisition will give Sanofi an experimental drug for alpha-1 antitrypsin deficiency, while the rest of Inhibrx's assets will be spun into a new...